Naomi Driesen

Dr. Naomi Driesen is a Research Scientist in Psychiatry at Yale School of Medicine, specializing in neuroimaging and the prefrontal cortex’s role in schizophrenia. She holds a PhD from the University of Memphis (1997), MA from the University of Virginia (1989), and BA from Yale University (1984). Her research focuses on schizophrenia, cognitive neuroscience, and the effects of ketamine on brain function, with over 20 years of publications in peer-reviewed journals. Notable studies include investigating ketamine’s impact on psychopathology and functional connectivity differences between schizophrenia and bipolar disorder. She collaborates on clinical trials involving AMPA receptor modulation and cannabinoid receptor imaging. Dr. Driesen’s work bridges neuroimaging, pharmacology, and psychiatric disorders, contributing to understanding cognitive deficits and therapeutic interventions.